A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants

Vaccines against SARS-CoV-2 have alleviated infection rates, hospitalization and deaths associated with COVID-19. In order to monitor humoral immunity, several serology tests have been developed, but the recent emergence of variants of concern has revealed the need for assays that predict the neutra...

Full description

Bibliographic Details
Main Authors: Leire Egia-Mendikute, Alexandre Bosch, Endika Prieto-Fernández, Laura Vila-Vecilla, Samanta Romina Zanetti, So Young Lee, Borja Jiménez-Lasheras, Ana García del Río, Asier Antoñana-Vildosola, Ander de Blas, Paloma Velasco-Beltrán, Marina Serrano-Maciá, Paula Iruzubieta, Majid Mehrpouyan, Edward M. Goldberg, Scott J. Bornheimer, Nieves Embade, María L. Martínez-Chantar, Marcos López-Hoyos, José M. Mato, Óscar Millet, Asís Palazón
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1014309/full